What Is Compounded Semaglutide and How Does It Work?
A clear, evidence-based look at how compounded semaglutide works on GLP-1 pathways to support appetite regulation and weight loss.
Compounded semaglutide is a once-weekly injectable that mimics the GLP-1 hormone to slow digestion and reduce appetite. When paired with lifestyle changes, it may support weight loss — though individual results vary and it is not FDA-approved.
What is compounded semaglutide?
Compounded semaglutide is a medication prepared by a licensed compounding pharmacy under a valid, patient-specific prescription from a healthcare provider. It contains semaglutide, a molecule that acts on the GLP-1 (glucagon-like peptide-1) receptor — the same pathway the body uses naturally to regulate appetite and digestion.
It's important to understand that compounded semaglutide is not an FDA-approved medication. The FDA does not review compounded drugs for safety, effectiveness, or quality. Compounded semaglutide is not a generic version of any brand-name product, and it is not affiliated with, endorsed by, or intended to replace FDA-approved medications such as Ozempic® or Wegovy® manufactured by Novo Nordisk.
How does semaglutide work in the body?
Semaglutide belongs to a class of medications called GLP-1 receptor agonists. These medications mimic the GLP-1 hormone that your digestive tract naturally releases when you eat. Here's what that pathway does:
- Appetite regulation: GLP-1 receptor activation signals to the brain that you're full, which can reduce hunger and food cravings.
- Slowed gastric emptying: Food moves more slowly from the stomach to the small intestine, helping you feel satisfied for longer after eating.
- Blood sugar influence: GLP-1 affects insulin and glucagon signaling, which plays a role in how your body manages blood sugar.
By acting on these pathways, semaglutide can help decrease hunger, reduce food cravings, improve eating control, and lower preference for high-fat foods. These effects may support adherence to a healthier diet when combined with lifestyle changes.
What does treatment look like?
Compounded semaglutide is typically prescribed as a once-weekly subcutaneous injection. There are no daily pills — just one small injection per week. A U.S.-licensed clinician reviews your medical history, determines whether the medication is appropriate for you, sets your starting dose, and remains accessible throughout treatment.
Every treatment plan begins with an individualized medical evaluation. If a clinician determines that semaglutide is not appropriate for you, you are not charged.
What does the research say?
GLP-1 receptor agonists have been studied extensively in clinical trials. The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program, published in the New England Journal of Medicine, examined semaglutide's effects on weight management. In the STEP 1 trial, participants receiving semaglutide alongside lifestyle intervention lost an average of 14.9% of their body weight over 68 weeks, with some individuals achieving up to 20% weight loss.
It's worth noting that these studies examined FDA-approved semaglutide, not compounded formulations. Individual results vary, and outcomes depend on factors including adherence, diet, physical activity, starting weight, and overall health status.
How is compounded semaglutide different from brand-name semaglutide?
Brand-name semaglutide products like Ozempic® and Wegovy® are FDA-approved and manufactured by Novo Nordisk. They have undergone FDA review for safety, effectiveness, and quality. Compounded semaglutide is prepared by a licensed 503A pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act, pursuant to a valid prescription from a licensed healthcare provider.
There are no FDA-approved generic versions of semaglutide. Compounded semaglutide is not a generic — generic drugs are FDA-approved and must demonstrate bioequivalence to the brand-name drug. Compounded medications do not go through that process.
What to expect when starting treatment
If a clinician determines that compounded semaglutide is appropriate for you, treatment typically follows a gradual titration schedule — meaning the dose is increased over time to help your body adjust. Consistent use, combined with healthy nutrition and regular physical activity, supports the medication's mechanism.
The timeline for results varies from person to person. Some individuals notice changes in appetite within the first few weeks, while weight changes may take longer to become noticeable. What matters most is consistency — taking the medication as directed and maintaining the lifestyle habits that support your goals.
Is compounded semaglutide right for you?
That's a decision only a licensed clinician can make after reviewing your full medical history. At EOS Health, the process starts with a brief online questionnaire. A U.S.-licensed physician reviews your intake, determines whether treatment is appropriate, and if so, ships your medication directly to your door at no extra cost.
If you're not approved, you receive a full refund — including any membership fees. Individual results vary, and treatment is not guaranteed.
Explore weight loss treatment options at EOS Health to see if a GLP-1 program may be right for you.
Sources
1. Wilding JPH, et al. "Semaglutide 2.4 mg Once-Weekly in Adults with Overweight or Obesity." New England Journal of Medicine, 2021; 384:989-1002. https://doi.org/10.1056/NEJMoa2032183
2. U.S. Food and Drug Administration. "Compounding and the FDA Questions and Answers." https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
3. Davies M, et al. "Semaglutide 2.4 mg for the Treatment of Obesity." NEJM, 2021; 384:1105-1116. https://doi.org/10.1056/NEJMoa2032196
faq
Common questions, answered.
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is not reviewed or approved by the FDA for safety, effectiveness, or quality. It is prepared by a licensed 503A pharmacy under a valid prescription. It is not a generic version of any FDA-approved product.
How is compounded semaglutide different from Ozempic or Wegovy?
Ozempic and Wegovy are FDA-approved brand-name medications manufactured by Novo Nordisk. Compounded semaglutide is prepared by a compounding pharmacy and is not affiliated with, endorsed by, or intended to replace those products. There are no FDA-approved generic versions of semaglutide.
How often do I take it?
Compounded semaglutide is typically prescribed as one subcutaneous injection per week. Your clinician sets your starting dose and adjusts it over time.
How much weight can I lose?
Individual results vary. Clinical studies of FDA-approved semaglutide showed an average weight loss of 14.9% of body weight over 68 weeks when combined with lifestyle changes. Your results depend on many factors, including adherence, diet, and activity level.
What happens if I'm not approved for treatment?
If a clinician determines that compounded semaglutide is not appropriate for you, you receive a full refund — including any membership fees you may have selected.
Do I need insurance?
No. EOS Health operates on a transparent pricing model with no insurance required. Pricing starts at $99 for the first month, then $199/month, regardless of dose.
Ready to feel like yourself again.™
Start free consultationwhat are you waiting for?
You're one click away from a new you.
Fill out our brief form and a licensed physician will evaluate which treatment plan is best for you.